Financials

News Discussions Technicals Seasonals

CMH fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Chordate Medical Holding AB is a medical technology company. It engages in the provision of developed, patented, and CE-marked product systems for neurostimulation treatment for the indications chronic migraine and chronic nasal congestion. The company was founded in February 2014 and is headquartered in Kista, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

CMH has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company